Musaffa Logo
Silk Road Medical Inc SILK

Last Updated: Sep 16, 12:00 AM·XDUS

SILK Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Silk Road Medical Inc is classified as halal.

HALAL

Report Source: 2024 2nd Quarter Report

Silk Road Medical Inc

Silk Road Medical Inc. Stock Analysis SILK

Germany Health Care Small Cap Report:
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 474 full-time employees. The firm has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. The company manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. The firm is a wholly owned subsidiary of Boston Scientific Corporation.
Read More

Silk Road Medical Inc (SILK) Chart

Key Statistics of Silk Road Medical Inc (SILK)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$27.49$27.51

Today's Open

$27.49

Volume

2.31M

P/E Ratio (TTM)

-

52 Week Range

$6.10$58.03

Market Cap

1.12B

Avg. Volume

1.32M

Dividend Yield

-

Financial Metrics & Statements of Silk Road Medical Inc (SILK)

Super Investors Invested in Silk Road Medical Inc (SILK)

FAQ's for Silk Road Medical Inc (SILK)

  • As of July 2026, Silk Road Medical Inc SILK is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Silk Road Medical Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Silk Road Medical Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Silk Road Medical Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Silk Road Medical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Silk Road Medical Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.